PlainPill

BPC-157 Intranasal

The short answer. There isn't much data on BPC-157 Intranasal yet — 3 mentions, 1 with a clear outcome — so treat these numbers as anecdotal. It is not an approved supplement and carries real risks.

What users report
0%helped1 reports · few reports
0 helped0 mixed1 didn't help

From 3 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
Not graded
High-risk compound. Peptides are not approved as supplements, carry serious and sometimes irreversible risks, are banned in competitive sport and may be restricted where you live. Nothing here is a recommendation to use it.

What BPC-157 Intranasal does, according to users

Of the people who reported each effect, the share who said it got better.

No specific effects reported yet.
betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

Research data for BPC-157 Intranasal is being compiled.

Dosage people report

We don't list doses for unapproved research compounds. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

sneezing ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

More peptides

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate